Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | GERN |
---|---|---|
09:32 ET | 202476 | 4.64 |
09:34 ET | 53494 | 4.605 |
09:36 ET | 21504 | 4.59 |
09:38 ET | 26536 | 4.58 |
09:39 ET | 11970 | 4.58 |
09:41 ET | 10150 | 4.595 |
09:43 ET | 50818 | 4.605 |
09:45 ET | 83172 | 4.62 |
09:48 ET | 62697 | 4.565 |
09:50 ET | 132998 | 4.55 |
09:52 ET | 17389 | 4.555 |
09:54 ET | 11127 | 4.575 |
09:56 ET | 44138 | 4.56 |
09:57 ET | 19339 | 4.56 |
09:59 ET | 9691 | 4.575 |
10:01 ET | 17431 | 4.595 |
10:03 ET | 33162 | 4.575 |
10:06 ET | 30228 | 4.6102 |
10:08 ET | 21616 | 4.64 |
10:10 ET | 17655 | 4.635 |
10:12 ET | 3751 | 4.635 |
10:14 ET | 16652 | 4.64 |
10:15 ET | 4417 | 4.64 |
10:17 ET | 16834 | 4.6364 |
10:19 ET | 11095 | 4.645 |
10:21 ET | 5730 | 4.65 |
10:24 ET | 28866 | 4.635 |
10:26 ET | 30679 | 4.645 |
10:28 ET | 30445 | 4.6328 |
10:30 ET | 19748 | 4.62 |
10:32 ET | 15267 | 4.635 |
10:33 ET | 20256 | 4.625 |
10:35 ET | 11585 | 4.63 |
10:37 ET | 34665 | 4.65 |
10:39 ET | 19884 | 4.645 |
10:42 ET | 6146 | 4.655 |
10:44 ET | 41082 | 4.665 |
10:46 ET | 93153 | 4.675 |
10:48 ET | 100607 | 4.635 |
10:50 ET | 42716 | 4.615 |
10:51 ET | 21047 | 4.605 |
10:53 ET | 51123 | 4.62 |
10:55 ET | 34588 | 4.625 |
10:57 ET | 7820 | 4.63 |
11:00 ET | 47425 | 4.63 |
11:02 ET | 31173 | 4.63 |
11:04 ET | 49202 | 4.61 |
11:06 ET | 39850 | 4.5841 |
11:08 ET | 34941 | 4.59 |
11:09 ET | 11372 | 4.59 |
11:11 ET | 7359 | 4.59 |
11:13 ET | 15283 | 4.585 |
11:15 ET | 5845 | 4.59 |
11:18 ET | 18123 | 4.595 |
11:20 ET | 6858 | 4.59 |
11:22 ET | 3148 | 4.59 |
11:24 ET | 10269 | 4.595 |
11:26 ET | 4729 | 4.59 |
11:27 ET | 18806 | 4.59 |
11:29 ET | 4400 | 4.59 |
11:31 ET | 3955 | 4.59 |
11:33 ET | 4068 | 4.58 |
11:36 ET | 12370 | 4.575 |
11:38 ET | 8424 | 4.585 |
11:40 ET | 4984 | 4.58 |
11:42 ET | 50625 | 4.595 |
11:44 ET | 10342 | 4.59 |
11:45 ET | 20891 | 4.58 |
11:47 ET | 9819 | 4.575 |
11:49 ET | 5953 | 4.58 |
11:51 ET | 8414 | 4.58 |
11:54 ET | 7946 | 4.58 |
11:56 ET | 18848 | 4.59 |
11:58 ET | 5844 | 4.585 |
12:00 ET | 4529 | 4.585 |
12:02 ET | 4695 | 4.58 |
12:03 ET | 4160 | 4.59 |
12:05 ET | 4277 | 4.59 |
12:07 ET | 96018 | 4.605 |
12:09 ET | 30929 | 4.62 |
12:12 ET | 27524 | 4.6307 |
12:14 ET | 106892 | 4.605 |
12:16 ET | 24463 | 4.595 |
12:18 ET | 25411 | 4.6 |
12:20 ET | 45342 | 4.585 |
12:21 ET | 4450 | 4.585 |
12:23 ET | 10509 | 4.575 |
12:25 ET | 1109 | 4.575 |
12:27 ET | 5530 | 4.57 |
12:30 ET | 17846 | 4.5784 |
12:32 ET | 4574 | 4.58 |
12:34 ET | 44599 | 4.555 |
12:36 ET | 14992 | 4.555 |
12:38 ET | 46654 | 4.57 |
12:39 ET | 98687 | 4.57 |
12:41 ET | 36887 | 4.565 |
12:43 ET | 40499 | 4.585 |
12:45 ET | 50414 | 4.57 |
12:48 ET | 24355 | 4.57 |
12:50 ET | 133026 | 4.585 |
12:52 ET | 107113 | 4.585 |
12:54 ET | 40919 | 4.59 |
12:56 ET | 53293 | 4.6 |
12:57 ET | 30422 | 4.595 |
12:59 ET | 10194 | 4.59 |
01:01 ET | 37701 | 4.575 |
01:03 ET | 7038 | 4.575 |
01:06 ET | 6187 | 4.58 |
01:08 ET | 40364 | 4.57 |
01:10 ET | 16523 | 4.55 |
01:12 ET | 31438 | 4.57 |
01:14 ET | 4168 | 4.57 |
01:15 ET | 6663 | 4.555 |
01:17 ET | 9488 | 4.56 |
01:19 ET | 49861 | 4.56 |
01:21 ET | 2985 | 4.555 |
01:24 ET | 32237 | 4.56 |
01:26 ET | 5537 | 4.56 |
01:28 ET | 26481 | 4.56 |
01:30 ET | 8074 | 4.57 |
01:32 ET | 7602 | 4.565 |
01:33 ET | 1400 | 4.57 |
01:35 ET | 13386 | 4.565 |
01:37 ET | 27306 | 4.59 |
01:39 ET | 8231 | 4.585 |
01:42 ET | 24362 | 4.58 |
01:44 ET | 5757 | 4.575 |
01:46 ET | 14118 | 4.58 |
01:48 ET | 5796 | 4.58 |
01:50 ET | 4873 | 4.575 |
01:51 ET | 20020 | 4.57 |
01:53 ET | 41770 | 4.565 |
01:55 ET | 2281 | 4.57 |
01:57 ET | 4107 | 4.57 |
02:00 ET | 19066 | 4.56 |
02:02 ET | 42847 | 4.545 |
02:04 ET | 3110 | 4.55 |
02:06 ET | 2589 | 4.54 |
02:08 ET | 44404 | 4.545 |
02:09 ET | 5511 | 4.545 |
02:11 ET | 30768 | 4.56 |
02:13 ET | 4300 | 4.56 |
02:15 ET | 2500 | 4.56 |
02:18 ET | 1785 | 4.56 |
02:20 ET | 2345 | 4.56 |
02:22 ET | 15577 | 4.57 |
02:24 ET | 7265 | 4.5649 |
02:26 ET | 25203 | 4.56 |
02:27 ET | 6163 | 4.555 |
02:29 ET | 6320 | 4.56 |
02:31 ET | 5213 | 4.555 |
02:33 ET | 12813 | 4.545 |
02:36 ET | 12547 | 4.56 |
02:38 ET | 2293 | 4.555 |
02:40 ET | 19469 | 4.565 |
02:42 ET | 700 | 4.565 |
02:44 ET | 1200 | 4.57 |
02:45 ET | 700 | 4.57 |
02:47 ET | 101055 | 4.575 |
02:49 ET | 40972 | 4.59 |
02:51 ET | 33174 | 4.605 |
02:54 ET | 32842 | 4.615 |
02:56 ET | 29432 | 4.615 |
02:58 ET | 18788 | 4.615 |
03:00 ET | 22499 | 4.615 |
03:02 ET | 22930 | 4.62 |
03:03 ET | 14029 | 4.625 |
03:05 ET | 397383 | 4.655 |
03:07 ET | 82245 | 4.665 |
03:09 ET | 17500 | 4.665 |
03:12 ET | 118474 | 4.655 |
03:14 ET | 43403 | 4.655 |
03:16 ET | 36594 | 4.655 |
03:18 ET | 28377 | 4.655 |
03:20 ET | 22850 | 4.655 |
03:21 ET | 130221 | 4.655 |
03:23 ET | 245262 | 4.625 |
03:25 ET | 50518 | 4.64 |
03:27 ET | 172069 | 4.63 |
03:30 ET | 31658 | 4.615 |
03:32 ET | 89630 | 4.65 |
03:34 ET | 244378 | 4.645 |
03:36 ET | 47034 | 4.635 |
03:38 ET | 27039 | 4.63 |
03:39 ET | 51933 | 4.625 |
03:41 ET | 58667 | 4.615 |
03:43 ET | 33567 | 4.615 |
03:45 ET | 20746 | 4.61 |
03:48 ET | 93268 | 4.62 |
03:50 ET | 53810 | 4.61 |
03:52 ET | 196389 | 4.62 |
03:54 ET | 251412 | 4.615 |
03:56 ET | 178160 | 4.585 |
03:57 ET | 88750 | 4.59 |
03:59 ET | 675508 | 4.59 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Geron Corp | 2.8B | -13.3x | --- |
Xenon Pharmaceuticals Inc | 2.8B | -13.8x | --- |
SpringWorks Therapeutics Inc | 2.7B | -7.0x | --- |
Structure Therapeutics Inc | 2.6B | -18.8x | --- |
IDEAYA Biosciences Inc | 2.8B | -18.5x | --- |
Biohaven Ltd | 3.0B | -5.1x | --- |
Geron Corporation is a late-stage clinical biopharmaceutical company developing investigational first-in-class telomerase inhibitor, imetelstat, to treat hematologic malignancies. The Company is engaged in the development of therapeutic products for oncology. Its lead indication for imetelstat is in Low or Intermediate-1 risk myelodysplastic syndromes. It is developing imetelstat for the treatment of several myeloid hematologic malignancies, including a Phase 3 clinical trial, named IMpactMF, in relapsed/refractory myelofibrosis (MF) with overall survival as the primary endpoint, that is enrolling patients. It is also conducting a Phase 1 combination therapy clinical trial, named IMproveMF, in first-line Intermediate-1, Intermediate-2 or High-Risk myelofibrosis, or frontline MF, that is enrolling patients and imetelstat is being studied in an investigator-led Phase 2 clinical trial, named IMpress, in Intermediate-2 or High-Risk myelodysplastic syndromes and acute myeloid leukemia.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.8B |
---|---|
Revenue (TTM) | $520.0K |
Shares Outstanding | 593.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.49 |
EPS | $-0.35 |
Book Value | $0.46 |
P/E Ratio | -13.3x |
Price/Sales (TTM) | 5,304.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -40,381.92% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.